Improved osteogenesis and upregulated immunogenicity in human placenta-derived mesenchymal stem cells primed with osteogenic induction medium

BACKGROUND: Mesenchymal stem cells (MSCs) are widely used in cell-based therapy owing to their multilineage potential and low immunogenicity. However, low differentiation efficiency and unpredictable immunogenicity of allogeneic MSCs in vivo limit their success in therapeutic treatment. Herein, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xuejie, Yang, Huilin, Zhang, Hui, Wang, Guichao, Liu, Ke, Gu, Qiaoli, Tao, Yunxia, Chen, Guangcun, Jiang, Xiaohua, Li, Gang, Gu, Yanzheng, Shi, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028975/
https://www.ncbi.nlm.nih.gov/pubmed/27649692
http://dx.doi.org/10.1186/s13287-016-0400-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028975/
https://www.ncbi.nlm.nih.gov/pubmed/27649692
http://dx.doi.org/10.1186/s13287-016-0400-6

Ejemplares similares